Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLASDEGIB vs GLATIRAMER: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLASDEGIB vs GLATIRAMER: Safety Overview

Metric GLASDEGIB GLATIRAMER
Total FAERS Reports 521 46,357
Deaths Reported 196 696
Death Rate 37.6% 1.5%
Hospitalizations 275 5,831
Average Patient Age 67.4 yrs 48.4 yrs
% Female Patients 38.6% 81.0%
FDA Approval Date Nov 21, 2018 Apr 16, 2015
Manufacturer Pfizer Laboratories Div Pfizer Inc Zydus Pharmaceuticals USA Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Discontinued